| Literature DB >> 22360933 |
Joyce Nolan Harrison1, Fallon Cluxton-Keller, Deborah Gross.
Abstract
The Food and Drug Administration has approved the use of antipsychotic medications in some children and adolescents with severe emotional and behavioral disorders. However, recent national data show a dramatic rise in off-label and Food and Drug Administration-approved uses of these medications. Of particular note is a twofold to fivefold increase in the use of antipsychotic medications in preschool children, despite little information on their long-term effects. This article describes the trend in pediatric antipsychotic medication use, possible explanations for the increase, implications for children's health, and recommendations for pediatric providers who work with parents of children and adolescents who seek or receive antipsychotic medication treatments. Copyright ÂEntities:
Mesh:
Substances:
Year: 2012 PMID: 22360933 PMCID: PMC3778027 DOI: 10.1016/j.pedhc.2011.10.009
Source DB: PubMed Journal: J Pediatr Health Care ISSN: 0891-5245 Impact factor: 1.812